Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 21, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - July 21, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 46     Next >>     Go To Page:

7/21/18 - U.S. FDA Approves Pfizer's Biosimilar NIVESTYM (filgrastim-aafi)
Pfizer, a pharmaceutical company, issued the following news release:. Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM (TM), a biosimilar to Neupogen, for all eligible indications of the reference product. "The FDA approval of NIVESTYM marks an important step in helping expand access to critical
7/20/18 - Dr. Reddy's Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market
HYDERABAD, India& PRINCETON, N.J. Dr. Reddy s Laboratories Ltd. today announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter therapeutic equivalent generic version of Nexium 24 HR Capsules in the United States market as approved by the U.S. Food and Drug Administration. The combined market
7/20/18 - FDA Issues Statement on Contaminated Illegal Synthetic Cannabinoid Products
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Commissioner Scott Gottlieb regarding the health risks of contaminated illegal synthetic cannabinoid products:. "The U.S. Food and Drug Administration has become aware of reports of severe illnesses and deaths resulting from the use of.
7/20/18 - HHS Secretary Azar Praises New FDA Effort to Advance Access to Over-the-Counter Drugs
Health and Human Services Secretary Alex Azar issued the following statement on the Food and Drug Administration's announcement of a guidance laying out new ways to empower patients with over-the-counter drugs:' FDA' s announcement is another step in our efforts to deliver on President Trump's blueprint to put American patients first.
7/20/18 - Immune Pharmaceuticals Announces Filing of Proxy Statement for Reverse Stock Split
Englewood Cliffs- Immune Pharmaceuticals, Inc., a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, announced today it has filed a definitive proxy statement with the Securities and Exchange Commission and will host a Special Meeting of Stockholders on August 22, 2018 to consid
7/20/18 - Innovus Pharma Signs Purchase Agreement with CVS Pharmacy, Inc. to Sell Its Product Androferti to Increase Sperm Quality in Their Newly Established In-Store Mens Clinic [T-break Tech (Middle East)]
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve mens and womens health and respiratory diseases, today announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS...
7/20/18 - Janssen Pharmaceutical - Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA is Being Stopped Early for Positive Efficacy Findings
RARITAN- The Janssen Pharmaceutical Companies of Johnson& Johnson today announced that the Phase 3 CREDENCE clinical trial, evaluating the efficacy and safety of INVOKANA versus placebo when used in addition to standard of care for patients with chronic kidney disease and type 2 diabetes, is being stopped early based on the achievement of pre-speci
7/20/18 - OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
MIAMI- OPKO Health, Inc. announced today that the Company's partner Vifor Fresenius Medical Care Renal Pharma has received approval from Health Canada to market RAYALDEE in Canada for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency. 'We established a global development an
7/20/18 - Statement from FDA Commissioner Scott Gottlieb, M.D. on new efforts to empower consumers by advancing access to nonprescription drugs
At the FDA, we're continuing to look at ways we can foster greater access to the medicines that help keep people healthy. We are considering all options for positively impacting both access and the cost of health care, and today we are announcing a new effort to establish innovative approaches to increase access to a broader selection of nonprescri
7/20/18 - U.S. FDA Approves Pfizer's Biosimilar NIVESTYM? (filgrastim-aafi)
Pfizer Inc. today announced that the United States Food and Drug Administration has approved NIVESTYM?, a biosimilar to Neupogen 1, for all eligible indications of the reference product. The FDA approval of NIVESTYM marks an important step in helping expand access to critical treatment options for patients with neutropenia, many of whom have c
7/19/18 - BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, today announced that the U.S. Food and Drug Administration has waived its requirement for a dermal carcinogenicity study for BPX-01, eliminating several years of non-clinical research normally required for FDA review. BPX-01, a novel topical
7/19/18 - Innovus Pharma Signs Purchase Agreement with CVS Pharmacy, Inc. to Sell Its Product Androferti to Increase Sperm Quality in Their Newly Established In-Store Men's Clinic
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women s health and respiratory diseases, today announced that it has entered into a pilot program with the nationwide pharmaceutical chain CVS
7/19/18 - International Ophthalmology and Optometry Devices Market Booming With New Growth Opportunities
Active healthcare stocks in the markets include: Eyecarrot Innovations Corp, STAAR Surgical Company, EyeGate Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Allergan plc.. Eyecarrot Innovations Corp BREAKING NEWS: Eyecarrot Innovations is pleased to announce it has secured a distribution deal with the leading Australasian...
7/19/18 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
7/19/18 - South African Pharmaceutical Industry 2017-2018 with 88 Company Profiles, including Pfizer, Aspen and Roche
The "The Pharmaceutical Industry in South Africa 2017" report has been added to ResearchAndMarkets.com' s offering. Also profiled are three companies that have been investigated by the Competition Commission in relation to the supply of various cancer medicines, Pfizer, Aspen and Roche and its US-based biotechnology company, Genentech.
7/19/18 - South African Pharmaceutical Industry 2017-2018 with 88 Company Profiles, including Pfizer, Aspen and Roche - ResearchAndMarkets.com
The "The Pharmaceutical Industry in South Africa 2017" report has been added to ResearchAndMarkets.com' s offering. Also profiled are three companies that have been investigated by the Competition Commission in relation to the supply of various cancer medicines, Pfizer, Aspen and Roche and its US-based biotechnology company, Genentech.
7/18/18 - "Regulatory Divergence: Failure of the Administrative State."
Mr. Chairman and Members of the Committee,. Public Citizen chairs the Coalition for Sensible Safeguards. Regulation is one of the greatest public policy success stories in terms of benefits to the public and is a testament to the power of Congress in protecting the public through passage of critical, foundational laws such as the Clean Air Act, the
7/18/18 - Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares
Avid Bioservices Inc Becton Dickinson and Co Eli Lilly And Co Genomic Health, Inc. Haemonetics Corporation IDEXX Laboratories, Inc. Kindred Biosciences Inc Medtronic PLC Momenta Pharmaceuticals, Inc. MORPHOSYS AG/ S ADR Reata Pharmaceuticals Inc ResMed Inc. Retrophin Inc Spectrum Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Down In The
7/18/18 - FDA eyes broader range of over-the-counter drugs
Food and Drug Administration director Scott Gottlieb said new pathways to selling drugs over the counter also could save consumers time and money because they would no longer need to see a doctor before shopping. Health and Human Services Secretary Alex Azar hailed the guidance as part of President Trump's broader effort to slash drug prices and "p
7/18/18 - FDA eyes broader range of over-the-counter drugs [Arab News (Saudi Arabia)]
Food and Drug Administrator Scott Gottlieb said expanding the universe of over-the-counter drugs will likely drive down costs and empower consumers by giving them more choices. Health Secretary Alex Azar hailed the guidance as part of President Trumps broader effort to slash drug prices and put American patients first. As envisioned, the FDA would.
7/18/18 - FDA Grants Breakthrough Therapy Designation for Genentech's TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for TECENTRIQ in combination with Avastin as an initial treatment for people with advanced or metastatic hepatocellular carcinoma, the most common form of liver cancer. Hepatocellular carcinoma is
7/18/18 - FDA Issues Statement on Advancing Access to Nonprescription Drugs
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Commissioner Scott Gottlieb on the efforts to empower consumers by advancing access to nonprescription drugs:. "At the FDA, we're continuing to look at ways we can foster greater access to the medicines that help keep people healthy.
7/18/18 - FDA plans to ease OTC approvals for some prescription drugs
U.S. regulators proposed new guidelines Tuesday to make it easier for some common medicines to be sold without a prescription- and more convenient for consumers to get them. The Food and Drug Administration is evaluating ways to make sure patients don't take an inappropriate over-the-counter drug, Commissioner Scott Gottlieb said in a statement.
7/18/18 - FDA to ease OTC approvals for some prescription drugs [Arab Times (Kuwait)]
The Food and Drug Administration wants to make it easier for some common medicines to be sold without a prescription. In a statement, FDA Commissioner Dr. Scott Gottlieb said the agency is evaluating ways to make sure consumers dont take an inappropriate over-the-counter drug.
7/18/18 - GNW-News: Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women (english)
Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal women; and as initial therapy with fulvestrant in postmenopausal women. Novartis International AG/ Novartis Kisqali now first and only CDK4/6 inhibitor indicated in US as first-line therapy specifically for premenopausal..
Articles(s): 1 - 25 of 46     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415